Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
SCD1 inhibitor-1
Cat. No.:
OB0425LY-040
Appearance:
Solid
Purity:
99.78%
Identity:
Confirmed by LC-MS.
Size:
Add to basket
Product Overview
Description:
SCD1 inhibitor-1 is an active and liver-selective inhibitor. It plays a key role in fatty acid metabolism, converting saturated fatty acids to unsaturated fatty acids.
Synonyms:
1069094-65-0; Sodium 2-[2-[[5-[(2-butylanilino)methyl]thiophene-2-carbonyl]amino]-1,3-thiazol-4-yl]acetate; Sodium 2-[2-(5-{[(2-butylphenyl)amino]methyl}thiophene-2-amido)-1,3-thiazol-4-yl]acetate
CAS No.:
1069094-65-0
Compound CID:
138454751
Specification
Target:
Stearoyl-CoA desaturase (SCD)
Pathway:
Metabolic enzyme/Protease
Solubility:
DMSO
Storage:
Storage at 4°C.
Applications:
SCD1 inhibitor-1 is mainly used in the study of metabolic diseases, such as obesity, diabetes and cardiovascular disease treatment research. In addition, the compound has potential applications in the areas of adipose tissue regulation and inflammation, and metabolic syndrome.
